S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?

Outset Medical (OM) Stock Price, News & Analysis

$2.20
0.00 (0.00%)
(As of 03/27/2024 ET)
Today's Range
$2.19
$2.31
50-Day Range
$1.99
$3.87
52-Week Range
$1.98
$24.13
Volume
373,766 shs
Average Volume
1.05 million shs
Market Capitalization
$111.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.13

Outset Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
133.0% Upside
$5.13 Price Target
Short Interest
Bearish
16.87% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$653,545 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.28) to ($2.23) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.54 out of 5 stars

Medical Sector

825th out of 939 stocks

Electromedical Equipment Industry

16th out of 18 stocks

OM stock logo

About Outset Medical Stock (NASDAQ:OM)

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Stock Price History

OM Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Why Dialysis Stocks Are up Today
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Q4 2023 Outset Medical Inc Earnings Call
Outset Medical Q4 2023 Earnings Preview
OM Mar 2024 4.000 put
Outset Medical Inc (OM)
OM May 2024 10.000 call
OM Feb 2024 10.000 put
5 Analysts Have This to Say About Outset Medical
See More Headlines
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
3/27/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Fax
N/A
Employees
480
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.13
High Stock Price Target
$6.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+133.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-172,800,000.00
Net Margins
-132.54%
Pretax Margin
-132.14%

Debt

Sales & Book Value

Annual Sales
$130.38 million
Book Value
$2.45 per share

Miscellaneous

Free Float
48,486,000
Market Cap
$111.12 million
Optionable
Not Optionable
Beta
2.04
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

OM Stock Analysis - Frequently Asked Questions

Should I buy or sell Outset Medical stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares.
View OM analyst ratings
or view top-rated stocks.

What is Outset Medical's stock price target for 2024?

5 brokers have issued twelve-month price targets for Outset Medical's stock. Their OM share price targets range from $3.00 to $6.00. On average, they predict the company's stock price to reach $5.13 in the next year. This suggests a possible upside of 133.0% from the stock's current price.
View analysts price targets for OM
or view top-rated stocks among Wall Street analysts.

How have OM shares performed in 2024?

Outset Medical's stock was trading at $5.41 on January 1st, 2024. Since then, OM shares have decreased by 59.3% and is now trading at $2.20.
View the best growth stocks for 2024 here
.

When is Outset Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our OM earnings forecast
.

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) announced its earnings results on Wednesday, February, 21st. The company reported ($0.77) earnings per share for the quarter, missing analysts' consensus estimates of ($0.74) by $0.03. The firm earned $30.51 million during the quarter, compared to the consensus estimate of $30.40 million. Outset Medical had a negative trailing twelve-month return on equity of 102.50% and a negative net margin of 132.54%.

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.8 million.

When did Outset Medical IPO?

Outset Medical (OM) raised $175 million in an initial public offering on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Who are Outset Medical's major shareholders?

Outset Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.85%), Vanguard Group Inc. (7.80%), Bellevue Group AG (3.51%), Mubadala Investment Co PJSC (2.85%), Assenagon Asset Management S.A. (2.03%) and PFM Health Sciences LP (1.99%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Marc Nash, Martin Vazquez, Nabeel Ahmed, Rebecca Chambers, Stacey L Porter, Steven S Williamson and Warburg Pincus Llc.
View institutional ownership trends
.

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OM) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners